Putnam Investments’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-447,181
Closed -$3.15M 1246
2016
Q3
$3.15M Buy
447,181
+395,700
+769% +$2.79M 0.01% 713
2016
Q2
$420K Hold
51,481
﹤0.01% 1217
2016
Q1
$419K Hold
51,481
﹤0.01% 1276
2015
Q4
$621K Hold
51,481
﹤0.01% 1266
2015
Q3
$616K Hold
51,481
﹤0.01% 1282
2015
Q2
$944K Buy
+51,481
New +$944K ﹤0.01% 1228